TCR2 Therapeutics Inc.
TCRRDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted in 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.7M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in TCR2 Therapeutics Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TCRR is no longer listed, so this page shows Q1 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 59
- −4 vs. Q4 2022
- Shares held
- 21.0M
- −208.4K (−1.0%) vs. Q4 2022
- Total value
- $31.5M
- +$10.3M (+48.7%) vs. Q4 2022
- New holders
- 7
- 12 more added
- Sold out
- 11
- 17 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 59 | $31.7M |
| Q4 2022 | 63 | $21.2M |
| Q3 2022 | 81 | $45.1M |
| Q2 2022 | 83 | $72.2M |
| Q1 2022 | 94 | $74.8M |
| Q4 2021 | 122 | $136.6M |
| Q3 2021 | 117 | $271.1M |
| Q2 2021 | 119 | $575.8M |
| Q1 2021 | 129 | $834.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Asset Management LLC | 4,050,865 | $6.08M | 2.53% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,399,745 | $5.10M | 0.76% | +660,798+24.1% | Added |
| MPM Oncology Impact Management LP | 3,370,982 | $5.06M | 1.31% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,468,802 | $2.20M | 0.00% | +37,456+2.6% | Added |
| Newtyn Management, LLC | 1,015,920 | $1.52M | 0.30% | −59,080−5.5% | Reduced |
| Acadian Asset Management LLC | 812,459 | $1.22M | 0.01% | −62,394−7.1% | Reduced |
| BlackRock Inc. | 789,911 | $1.18M | 0.00% | −962−0.1% | Reduced |
| Baker Bros. Advisors LP | 753,064 | $1.13M | 0.01% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $1.13M | 0.07% | 00.0% | Unchanged |
| Redmile Group, LLC | 658,336 | $987.5K | 0.04% | −73,043−10.0% | Reduced |
| Long Focus Capital Management, LLC | 566,270 | $849.4K | 0.14% | +566,270 | New |
| JPMorgan Chase & Co | 524,184 | $787.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 444,800 | $667.0K | 0.00% | −248,486−35.8% | Reduced |
| Citigroup Inc | 383,486 | $575.2K | 0.00% | −89,998−19.0% | Reduced |
| Geode Capital Management, LLC | 315,377 | $473.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 181,810 | $272.7K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 171,214 | $256.7K | 0.00% | −38,904−18.5% | Reduced |
| Morgan Stanley | 155,390 | $233.1K | 0.00% | +108,995+234.9% | Added |
| State Street Corp | 137,219 | $205.8K | 0.00% | +27,900+25.5% | Added |
| FMR LLC | 120,633 | $180.9K | 0.00% | +6,772+5.9% | Added |
| Two Sigma Advisers, LP | 111,000 | $166.5K | 0.00% | −138,653−55.5% | Reduced |
| Northern Trust Corp | 93,933 | $140.9K | 0.00% | +7,441+8.6% | Added |
| Cornercap Investment Counsel Inc | 71,046 | $106.6K | 0.02% | +3,011+4.4% | Added |
| Harbor Capital Advisors, Inc. | 67,642 | $101.5K | 0.03% | −588−0.9% | Reduced |
| Ergoteles LLC | 57,279 | $85.9K | 0.00% | +12,129+26.9% | Added |
| Price T Rowe Associates Inc | 48,900 | $74.0K | 0.00% | 00.0% | Unchanged |
| Sagefield Capital LP | 43,900 | $65.8K | 0.02% | +43,900 | New |
| Wells Fargo & Company | 40,688 | $61.0K | 0.00% | +14,004+52.5% | Added |
| Oppenheimer & Co Inc | 37,950 | $56.9K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 37,452 | $56.0K | 0.01% | +37,452 | New |
| Two Sigma Investments, LP | 36,000 | $54.0K | 0.00% | −84,677−70.2% | Reduced |
| Barclays PLC | 33,116 | $49.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 31,683 | $48.0K | 0.00% | −108,358−77.4% | Reduced |
| X-Square Capital, LLC | 31,720 | $48.0K | 0.03% | −199−0.6% | Reduced |
| Commonwealth Equity Services, LLC | 24,973 | $37.0K | 0.00% | +2,500+11.1% | Added |
| Charles Schwab Investment Management Inc | 22,638 | $34.0K | 0.00% | +22,638 | New |
| Bank of America Corp | 21,166 | $31.7K | 0.00% | −62,372−74.7% | Reduced |
| HSBC Holdings PLC | 17,257 | $25.5K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,755 | $19.1K | 0.00% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 12,522 | $18.8K | 0.01% | 00.0% | Unchanged |
| Independent Financial Group, LLC | 12,075 | $18.1K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 10,765 | $16.1K | 0.00% | −956−8.2% | Reduced |
| HRT Financial LP | 11,024 | $16.0K | 0.00% | −1,840−14.3% | Reduced |
| Tower Research Capital LLC (TRC) | 7,678 | $11.0K | 0.00% | +741+10.7% | Added |
| Federated Hermes, Inc. | 7,081 | $10.6K | 0.00% | −9,630−57.6% | Reduced |
| Lindbrook Capital, LLC | 3,050 | $4.58K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,801 | $2.70K | 0.00% | +451+33.4% | Added |
| Simplex Trading, LLC | 1,444 | $2.00K | 0.00% | +1,444 | New |
| HighMark Wealth Management LLC | 840 | $1.26K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 800 | $1.20K | 0.00% | +800 | New |
| US Bancorp | 700 | $1.05K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 500 | $750 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 234 | $351 | 0.00% | +234 | New |
| BNP Paribas Arbitrage, SA | 140 | $210 | 0.00% | −545−79.6% | Reduced |
| Beaird Harris Wealth Management, LLC | 61 | $92 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 35 | $53 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 15 | $23 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 85 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −233,876−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −120,389−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −74,297−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −41,295−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −32,803−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −31,992−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −26,600−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,204−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −2,147−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |